Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: A randomized controlled trial

JAMA

Volumn 301, Issue 2, 2009, Pages 175-182

  Makrides, Maria ^a,b,e   Gibson, Robert A ^a,c   McPhee, Andrew J ^a   Collins, Carmel T ^a,b   Davis, Peter G ^f   Doyle, Lex W ^f   Simmer, Karen ^g   Colditz, Paul B ^h   Morris, Scott ^d   Smithers, Lisa G ^a,b,e   Willson, Kristyn ^c   Ryan, Philip ^c  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d FLINDERS MEDICAL CENTRE   (Australia)

^e FLINDERS UNIVERSITY   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID;

ARTICLE; BODY WEIGHT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INFANT FEEDING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NERVE GROWTH; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; TERTIARY HEALTH CARE; CHILD DEVELOPMENT; DIET SUPPLEMENTATION; GROWTH, DEVELOPMENT AND AGING; NEUROPSYCHOLOGICAL TEST; NEWBORN; RANDOMIZED CONTROLLED TRIAL;

CHILD DEVELOPMENT; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; NEUROPSYCHOLOGICAL TESTS;

EID: 58249088832     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2008.945     Document Type: Article

References (34)

1. Anderson PJ, Doyle LW. Cognitive and educational deficits in children born extremely preterm. Semin Perinatol. 2008;32(1):51-58.
2. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008;371(9608):261-269.
3. Larroque B, Ancel P-Y, Marret S, et al; EPIPAGE Study Group. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet. 2008;371(9615):813-820.
4. Reijneveld SA, de Kleine MJK, van Baar AL, et al. Behavioural and emotional problems in very preterm and very low birthweight infants at age 5 years. Arch Dis Child Fetal Neonatal Ed. 2006;91(6):F423-F428.
5. Salt A, Redshaw M. Neurodevelopmental follow-up after preterm birth: follow up after two years. Early Hum Dev. 2006;82(3):185-197.
6. Anderson P, Doyle LW; Victorian Infant Collaborative Study Group. Neurobehavioral outcomes of school-age children born extremely low birth weight or very preterm in the 1990s. JAMA. 2003;289(24):3264-3272.
7. Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJS. Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA. 2002;288(6):728-737.
8. Clandinin MT, Chappell JE, Heim T, Swyer PR, Chance GW. Fatty acid utilization in perinatal de novo synthesis of tissues. Early Hum Dev. 1981;5(4):355-366.
9. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr. 1992;120(4 pt 2)(suppl):S129-S138.
10. Clandinin MT, Van Aerde JE, Merkel KL, et al. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J Pediatr. 2005;146(4):461-468.
11. Fewtrell MS, Abbott RA, Kennedy K, et al. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J Pediatr. 2004;144(4):471-479.
12. Fewtrell MS, Morley R, Abbott RA, et al. Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants. Pediatrics. 2002;110(1 Pt 1):73-82.
13. O'Connor DL, Hall R, Adamkin D, et al; Ross Preterm Lipid Study. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics. 2001;108(2):359-371.
14. Vanderhoof J, Gross S, Hegyi T, et al. Evaluation of a long-chain polyunsaturated fatty acid supplemented formula on growth, tolerance, and plasma lipids in preterm infants up to 48 weeks postconceptional age. J Pediatr Gastroenterol Nutr. 1999;29(3):318-326.
15. Carlson SE, Werkman SH, Tolley EA. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am J Clin Nutr. 1996;63(5):687-697.
16. Birch EE, Birch D, Hoffman DR, Uauy R. Dietary essential fatty acid supply and visual acuity development. Invest Ophthalmol Vis Sci. 1992;33(11):3242-3253.
17. Carlson SE, Cooke R, Werkman S, Tolley E. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids. 1992;27(11):901-907.
18. Carlson SE, Werkman SH, Rhodes PG, Tolley EA. Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation. Am J Clin Nutr. 1993;58(1):35-42.
19. Smithers LG, Gibson RA, McPhee A, Makrides M. Effect of long-chain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment: a systematic review of randomized controlled trials. Am J Clin Nutr. 2008;87(4):912-920.
20. Simmer K, Schulzke SM, Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev. 2008;(1):CD000375.
21. Henriksen C, Haugholt K, Lindgren M, et al. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics. 2008;121(6):1137-1145.
22. Makrides M, Neumann MA, Gibson RA. Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr. 1996;50(6):352-357.
23. Bayley N. Manual for the Bayley Scales of Infant Development, Second Edition (BSID-II). San Antonio, TX: Psychological Corp; 1993.
24. Lucas A, Morley R, Cole TJ, Lister G, Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born preterm. Lancet. 1992;339(8788):261-264.
25. Frankenburg WK, Coons CE. Home Screening Questionnaire: its validity in assessing home environment. J Pediatr. 1986;108(4):624-626.
26. Marlow N, Hennessy EM, Bracewell MA, Wolke D; Epicure Study Group. Motor and executive function at 6 years of age after extremely preterm birth. Pediatrics. 2007;120(4):793-804.
27. Hintz SR, Kendrick DE, Vohr BR, Poole WK, Higgins RD. Gender differences in neurodevelopmental outcomes among extremely preterm, extremely-low- birthweight infants. Acta Paediatr. 2006;95(10):1239-1248.
28. Marlow N, Wolke D, Bracewell MA, Samara M; Epicure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med. 2005;352(1):9-19.
29. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13-22.
30. Abeywardana S. The Report of the Australian and New Zealand Neonatal Network, 2004. Sydney, Australia: Australian and New Zealand Neonatal Network; 2006.
31. Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev. 2005;45(5):581-597.
32. Gibson RA, Neumann MA, Makrides M. Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur J Clin Nutr. 1997;51(9):578-584.
33. Blanco PG, Freedman S, Lopez M, et al. Oral docosahexaenoic acid given to pregnant mice increases the amount of surfactant in lung and amniotic fluid in preterm fetuses. Am J Obstet Gynecol. 2004;190(5):1369-1374.
34. Chao AC, Ziadeh BI, Diau G-Y, et al. Influence of dietary long-chain PUFA on premature baboon lung FA and dipalmitoyl PC composition. Lipids. 2003;38(4):425-429.